I manage research and monitoring for the South Asian Vulture Crisis Programme. In recent decades, the once abundant vultures populations in South Asia crashed. The cause of these declines was the common and widespread use of a veterinary drug called diclofenac. Veterinary diclofenac is now banned throughout South Asia and effective alternative drug, meloxicam, is widely available and not toxic to vultures. However, vulture populations remain dangerously small and the above veterinary drugs are not the only ones vultures are exposed to.
I work with BirdLife partners in India and Nepal and SAVE (Saving Asia's Vultures from Extinction) partners worldwide to monitor vulture populations and veterinary drug use; determine toxicity of drugs to vultures and intolerance in other species to these drugs; and study the behavior and fate of wild and captive-released vultures.
I am also involved in the research of many other species worldwide through the RSPB/Birdfair Research Fund for Endangered Birds, which funds and guides approximately eight small projects per year.
- 2015 to present: Chairman, RSPB/Birdfair Research Fund for Endangered Birds
- 2014 to present: Member, SAVE (Saving Asia's Vultures from Extinction) Technical Advisory Committee
- 2014 to present: Conservation Officer, Oriental Bird Club Conservation Fund Awards
Partners and Collaboration
- Dr Vibhu Prakash, Bombay Natural History Society, India
- Mr Krishna Bhusal, Bird Conservation Nepal, Nepal
- Dr Mark Taggart, Environmental Research Institute, University of the Highlands and Islands, UK
- Prof Vinny Naidoo, Department of Paraclinical Sciences, University of Pretoria, South Africa